TABLE IV.

Multivariable analysis, competing risks model

Characteristic	HR	95% CI	Wald p
Age group at diagnosis
<25 Years	0.45	0.33 to 0.63	<0.001
25–45 Years	0.75	0.68 to 0.83	<0.001
45–60 Years	Reference
>60 Years	1.13	1.03 to 1.25	0.013
FIGO stage (1994)
In situ	0.06	0.05 to 0.08	<0.001
I	Reference
II	2.48	2.21 to 2.78	<0.001
III	3.45	3.00 to 3.97	<0.001
IV	5.40	4.55 to 6.41	<0.001
Lymph node metastasis
No metastasis	0.32	0.27 to 0.37	<0.001
Regional	0.73	0.62 to 0.85	<0.001
Distant	Reference
Histology
Squamous cell	Reference
Adenocarcinoma	1.30	1.18 to 1.44	<0.001
Adenosquamous	1.66	1.41 to 1.94	<0.001
Others	1.78	1.52 to 2.07	<0.001
Radiation
Yes	1.12	1.07 to 1.16	<0.001
No	Reference
Surgery
Yes	0.47	0.42 to 0.52	<0.001
No	Reference
Ethnicity
Asian American	Reference
White	1.25	1.11 to 1.40	<0.001

HR = hazard ratio; CI = confidence interval; FIGO = Fédération Internationale de Gynécologie et d’Obstétrique.